Genuine Parts – Good Riddance Business Products Group

Summary On April 12, 2018, Genuine Parts (GPC) and Essendant (ESND) announced that the companies had entered into a definitive agreement to combine ESND and GPC’s S.P. Richards (SPR) business. On April 19, 2018, GPC reported Q1 results which reflected double digit sales growth but income before taxes experienced some challenges. Management has maintained its [...]

By |April 19th, 2018|Equity Investing|Comments Off on Genuine Parts – Good Riddance Business Products Group

Parker-Hannifin – Temper Your Expectations

Summary Parker-Hannifin is a Dividend King having increased its annual dividend for at least 50 consecutive years. While the diluted - weighted-average common shares outstanding has been reduced dramatically since FY2008 and EPS has grown significantly since such time, there are other metrics that suggest PH is an unsuitable investment for me at this juncture. [...]

By |April 17th, 2018|Equity Investing|Comments Off on Parker-Hannifin – Temper Your Expectations

Prestige Brands – Far Too Much Leverage

Summary Prestige Brands is a small cap company engaged in the business of marketing, sales, manufacturing and distribution of well-recognized, brand name, over-the-counter (“OTC”) healthcare and household cleaning products. It crossed my radar in December 2011 when it acquired 17 over-the-counter medicine brands sold in North America from GlaxoSmithKline Plc for $660 million cash. I [...]

By |April 14th, 2018|Equity Investing|Comments Off on Prestige Brands – Far Too Much Leverage

Altra Industrial Motion Corp. Stock Analysis

Summary Altra is a small cap company which does not fit my investor profile. Some readers, however, have requested I conduct the occasional review on small cap investment opportunities hence this analysis. Altra released its Q4 and FY2017 results on February 21, 2018 and within days it announced a proposal to amalgamate with 4 operating [...]

By |April 13th, 2018|Equity Investing|Comments Off on Altra Industrial Motion Corp. Stock Analysis

West Pharmaceutical Stock Analysis

Summary WST has been in business for 95 years and has developed a strong reputation. The top 50 injectable biologics rely on WST and also supplies the top 75 pharmaceutical and biotech injectable companies. The company’s common stock cumulative total return has far exceeded the cumulative total return of the following Standard & Poor's (“S&P”) [...]

By |April 11th, 2018|Equity Investing|Comments Off on West Pharmaceutical Stock Analysis

RPM International – I See Some Red Flags

Summary This RPM stock analysis is based on Q3 2018 results released on April 5, 2018. RPM increased its dividend in October 2017 thus marking its 44th consecutive year of dividend increases. The dividend compound annual growth rate for the 2001 – 2018, however, is only ~5.7%. RPM’s returns since May 31, 2007 have outperformed [...]

By |April 6th, 2018|Equity Investing|Comments Off on RPM International – I See Some Red Flags

Paychex – Fairly Valued After Pullback

Summary Paychex reported strong Q3 results on March 26th and earlier in March it announced an acquisition in Germany which will offer PAYX the opportunity to expand its market penetration in Europe. The balance sheet is pristine and it continues to generate strong free cash flow. PAYX’s stock valuation has retraced from recent highs to [...]

By |March 27th, 2018|Equity Investing|Comments Off on Paychex – Fairly Valued After Pullback

Nike – Fully Valued

Summary NKE reported Q3 results March 22, 2018 which were better than expected when the one-time ~$2B impact from the Tax Cuts and Job Act is excluded. Despite the tax hit, NKE has indicated the TCJ is slightly favorable in terms of its normalized steady state effective tax rate and because it will provide NKE [...]

By |March 24th, 2018|Equity Investing|Comments Off on Nike – Fully Valued

Ecolab – Good Company But a Bit Expensive

Summary Ecolab (ECL) has a track record of two decades of double digit EPS growth. It is a very low capital intensive company with highly consumable products/services thereby resulting in a predictable and highly recurring revenue stream. Bill Gates has held a position in ECL for some time and just recently acquired another ~1.3 million [...]

By |March 14th, 2018|Equity Investing|Comments Off on Ecolab – Good Company But a Bit Expensive

Disney – Too Many Uncertainties

Summary DIS has offered to acquire certain 21st Century Fox, Inc. assets for $52B to help it expand into the direct-to-consumer streaming distribution business. The stock is attractively valued based on forward EPS and free cash flow. Despite the attractive valuation, I have several reasons why I will not initiate a position in DIS at [...]

By |March 9th, 2018|Equity Investing|Comments Off on Disney – Too Many Uncertainties
Go to Top